Mesothelioma Specialists
A specialist who is regularly treating mesothelioma is aware of what to look out for in blood tests, imaging tests and other diagnostic tools. Mesothelioma doctors can also provide advanced treatments that can improve the prognosis.
When selecting a mesothelioma physician be sure to consider the hospital affiliation, experience and availability. Patients should feel at ease and supported at each visit.
Raja Flores
Dr. Raja Flores is a highly regarded mesothelioma specialist known for his compassion for patients and surgical skills. He is the director of thoracic surgery at Mount Sinai Medical Center, New York City.
Flores developed his expertise in treating lung cancer and mesothelioma during his time at Brigham and Women's Hospital. He received training from the renowned mesothelioma specialist Dr. David Sugarbaker. He is well-versed in the treatment of mesothelioma of the pleural region lung cancer, esophageal and lung cancer.
He helped pioneer the lung-sparing pleurectomy/decortication surgery that has been successfully used as a curative procedure in scores of mesothelioma cases. He was also instrumental to the development of the video-assisted surgery for thoracic (VATS) lobectomy which is now considered the most effective treatment for lung cancer. This minimally-invasive procedure involves only three small cuts to remove diseased areas of the lung.
During his mesothelioma treatment career, Flores has published more than 100 peer-reviewed research articles and book chapters. He has received many professional honors including being named as a New York Top Doctor and America Top Doctor. He has also been involved in several clinical studies. One of these examined the effectiveness of in mesothelioma neoadjuvant treatment.
Mesothelioma can be detected through a physical exam or blood tests, as well as imaging. Patients might not be able to show signs until the disease has reached an advanced stage. If this happens, they may feel pain in their throat, abdomen or chest, fatigue, coughing and difficulty breathing. A doctor can remove the excess fluid to check for cancer cells and determine if a patient has mesothelioma that is mixed or epitheliod.
Asbestos exposure is a major reason for mesothelioma. People who are exposed to asbestos during the construction, maintenance, and repair of ships, power stations, or factories are at a greater chance of developing mesothelioma.
A multidisciplinary team can offer patients the most effective treatment for mesothelioma. In addition to the surgeon patients should consult medical oncologists and radiation specialists who specialize in mesothelioma treatments. These specialists can formulate an action plan to treat the cancer using radiotherapy and chemotherapy. It is also crucial for mesothelioma sufferers to inquire with their doctors about how many mesothelioma cases have they treated.
Robert Cameron
Robert Cameron, a renowned mesothelioma expert graduated from UCLA's medical school nearly 30 years ago. Prior to pursuing his mesothelioma-specific training in the year 2000, he had completed surgical residencies at the National Cancer Institute and Cornell University Medical Center. His mesothelioma patients benefit from his expertise in lung-sparing surgery and minimally invasive techniques such as thorascopic surgeries. Cameron is a mesothelioma researcher and has published over 35 articles on thoracic and oncology.
He is co-founder of the Mesothelioma Applied Research Foundation and is the scientific advisor for the Pacific Mesothelioma Center. He is also the chief of thoracic surgery at both the University of California Los Angeles and West Los Angeles Veterans Affairs Medical Center mesothelioma treatment programs.
Dr. Cameron has helped thousands asbestos victims and is a pioneer when it comes to mesothelioma treatments. He is focused on improving the mesothelioma treatment quality and ensuring that patients can access the most effective mesothelioma specialists. He is also a strong advocate for patients and their families throughout the process of treatment.
As a specialist in mesothelioma, Cameron has expertise in treating both pleural and peritoneal mesothelioma. Cameron is experienced in a variety of surgical mesothelioma treatment options, such as cytoreductive surgeries as well as hyperthermic intraperitoneal chemotherapy and pleurectomy/decortication. He has also treated pericardial cancer by surgical removal of tumors in the lining of the heart and the surrounding tissue.
When searching for a mesothelioma specialist it is crucial to find one that has privileges at a cancer facility you can trust. A top specialist has the expertise, staff, equipment, and clinical trials necessary to give you the treatment you require. Additionally, it is important to bring any relevant work history records and scans of your imaging to your appointment. You might also want to bring an individual from your family or a close friend along with you for support and to help you remember important information at your appointment.
If you are not looking to undergo surgery or are not able to undergo it, there are other options for mesothelioma treatments like immunotherapy and radiation. Many mesothelioma specialists are skilled in coordinating these additional treatment options that include surgery. The mesothelioma specialists at your cancer center can aid in making these decisions after a mesothelioma diagnoses.
Raphael Bueno
Bueno is an expert in the treatment of thoracic cancers, including mesothelioma. He is currently trying to improve the way mesothelioma and other lung cancers are prevented, diagnosed and treated. Bueno's work is helping doctors to understand mesothelioma on the molecular level. This will make it easier for mesothelioma patients to be diagnosed, and could lead to new ways of treatment.
Raphael Bueno, Chief of Thoracic Surgery and vice-chair of Surgery for Cancer Research in Brigham and Women's Hospital is dedicated to preserving Brigham and Women's Hospital's position as a world-class leader in mesothelioma research and treatment. Bueno is the director of the hospital's International Mesothelioma Program and has a broad spectrum of expertise in mesothelioma diagnosis treatment, prevention and treatment.
While leadership, patient care, and teaching were all important aspects of his professional life but his time at BWH has been dominated by research. He has developed tests to aid surgeons detect mesothelioma during a surgical biopsies. He is also developing techniques that will make the procedure less invasive. He is also researching mesothelioma's gender-specific characteristics, and how tumors develop.
Bueno began working at BWH as a surgical trainee after he graduated from Harvard Medical School. He gained a lot of knowledge about mesothelioma while working with Dr. David Sugarbaker. After his internship, he completed a cardiothoracic surgical residency at Massachusetts General Hospital. He then returned to BWH and set up a private surgery practice and an experimental laboratory for mesothelioma.
One of his most notable achievements is the development of iVats. This system allows surgeons to precisely locate mesothelioma tumours and remove them during an extrapleural lung pneumonectomy. This technique is a significant improvement over the conventional approach, which is often inaccurate and requires more tissue to be removed than is necessary. Moreover, the new technique has resulted in better outcomes for mesothelioma patients.
Bueno is involved in many clinical trials to develop innovative methods for mesothelioma diagnosis and treatment. He is a Dana-Farber Cancer Institute member and has appointments at Brigham and Women's Faulkner Hospital and Carney Hospital. He is a fellow of American College of Chest Physicians.
Paul Sugarbaker
Paul Sugarbaker is a nationally recognized mesothelioma specialist, known for his work in peritoneal mesothelioma and abdominal cancers. His innovative treatment of this rare cancer and expanding the scope of treatment helped increase the odds of survival. He developed, perfected and then popularized the method of combining cancer surgery with chemotherapy heated to treat peritoneal mesothelioma. This unique procedure is now referred to as the Sugarbaker Method. He continues to travel around the world to teach young surgeons about this innovative procedure.
A mesothelioma expert has years of experience in treating asbestos-related diseases. They may also have experience with the most current mesothelioma treatment, as well as clinical trials. Patients suffering from mesothelioma must be prepared by bringing medical records, a list questions and a willingness to talk prior to their first appointment with a specialist.
There are various types of mesothelioma physicians and each will have their own specialization. They include thoracic surgeons general surgeons, pulmonologists radiation oncologists and pathologists. Each of these mesothelioma specialists is a key player in the care of patients.
A thoracic surgery specialist treats chest tumors, cancers, and other chest problems. They may perform lung surgery to eliminate tumors and improve breathing abilities. Jersey City mesothelioma lawyers may prescribe medication to treat symptoms or prolong the life duration.
A thoracic specialist can assist patients who have the most difficult treatment options. They can also help patients find mesothelioma support group and other sources.
Paul Sugarbaker earned his undergraduate degree at Wheaton College, located in Illinois. He completed his surgical residency in Boston at Peter Bent Brigham Hospital, an affiliated program of Harvard University. Then, he moved to Atlanta, Georgia, where he worked for Emory University in Atlanta for two years, before returning to Washington, D.C.
Paul Sugarbaker is an internationally well-known cancer surgeon and surgeon. He has been named one of America’s Top Doctors, and he is a member of many professional associations. He is well-known for his relentless search for a cure for mesothelioma of the peritoneal region, which led to the HIPEC (heated intraperitoneal chemotherapy) procedure which has been proven to prolong the lives of patients with this rare type of cancer.